These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36843616)

  • 21. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study.
    Hoeger KM; Kochman L; Wixom N; Craig K; Miller RK; Guzick DS
    Fertil Steril; 2004 Aug; 82(2):421-9. PubMed ID: 15302293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic health during a randomized controlled lifestyle intervention in women with PCOS.
    Dietz de Loos A; Jiskoot G; Beerthuizen A; Busschbach J; Laven J
    Eur J Endocrinol; 2021 Nov; 186(1):53-64. PubMed ID: 34714771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implementing the international evidence-based guideline of assessment and management of polycystic ovary syndrome (PCOS): how to achieve weight loss in overweight and obese women with PCOS?
    Lie Fong S; Douma A; Verhaeghe J
    J Gynecol Obstet Hum Reprod; 2021 Jun; 50(6):101894. PubMed ID: 32814159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin resistance in a large cohort of women with polycystic ovary syndrome: a comparison between euglycaemic-hyperinsulinaemic clamp and surrogate indexes.
    Tosi F; Bonora E; Moghetti P
    Hum Reprod; 2017 Dec; 32(12):2515-2521. PubMed ID: 29040529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum antimüllerian hormone in response to dietary management and/or physical exercise in overweight/obese women with polycystic ovary syndrome: secondary analysis of a randomized controlled trial.
    Nybacka Å; Carlström K; Fabri F; Hellström PM; Hirschberg AL
    Fertil Steril; 2013 Oct; 100(4):1096-102. PubMed ID: 23876536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sleep disturbances in a community-based sample of women with polycystic ovary syndrome.
    Moran LJ; March WA; Whitrow MJ; Giles LC; Davies MJ; Moore VM
    Hum Reprod; 2015 Feb; 30(2):466-72. PubMed ID: 25432918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Weight Management in Adolescents with Polycystic Ovary Syndrome.
    Moore JM; Waldrop SW; Cree-Green M
    Curr Obes Rep; 2021 Sep; 10(3):311-321. PubMed ID: 34043216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obesity and depression are risk factors for future eating disorder-related attitudes and behaviors in women with polycystic ovary syndrome.
    Greenwood EA; Pasch LA; Cedars MI; Huddleston HG
    Fertil Steril; 2020 May; 113(5):1039-1049. PubMed ID: 32386615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lifestyle and Behavioral Management of Polycystic Ovary Syndrome.
    Brennan L; Teede H; Skouteris H; Linardon J; Hill B; Moran L
    J Womens Health (Larchmt); 2017 Aug; 26(8):836-848. PubMed ID: 28570835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Barriers and facilitators to weight management in overweight and obese women living in Australia with PCOS: a qualitative study.
    Lim S; Smith CA; Costello MF; MacMillan F; Moran L; Ee C
    BMC Endocr Disord; 2019 Oct; 19(1):106. PubMed ID: 31647000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of a Dulaglutide plus Calorie-Restricted Diet versus a Calorie-Restricted Diet on Visceral Fat and Metabolic Profiles in Women with Polycystic Ovary Syndrome: A Randomized Controlled Trial.
    Zhang Y; Qu Z; Lu T; Shao X; Cai M; Dilimulati D; Gao X; Mao W; Hu F; Su L; Liao Q; Han T; Zhang M; Qu S
    Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obese but not normal-weight women with polycystic ovary syndrome are characterized by metabolic and microvascular insulin resistance.
    Ketel IJ; Stehouwer CD; Serné EH; Korsen TJ; Hompes PG; Smulders YM; de Jongh RT; Homburg R; Lambalk CB
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3365-72. PubMed ID: 18593766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility and acceptability of a proposed trial of acupuncture as an adjunct to lifestyle interventions for weight loss in Polycystic Ovary Syndrome: a qualitative study.
    Ee C; Smith C; Costello M; MacMillan F; Moran L; Baylock B; Teede H
    BMC Complement Altern Med; 2018 Nov; 18(1):298. PubMed ID: 30409195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atherogenic changes in low-density lipoprotein particle profiles were not observed in non-obese women with polycystic ovary syndrome.
    Kim JJ; Chae SJ; Choi YM; Hwang KR; Song SH; Yoon SH; Kim SM; Ku SY; Kim SH; Kim JG; Moon SY
    Hum Reprod; 2013 May; 28(5):1354-60. PubMed ID: 23477907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usage of mobile health interventions among overweight/obese PCOS patients undergoing assisted reproductive technology treatment during the COVID-19 pandemic.
    Sang M; Wu Q; Tao Y; Huang F; Lu L; Zhou W; Li A; Bai S
    Gynecol Endocrinol; 2022 Sep; 38(9):776-780. PubMed ID: 35993296
    [No Abstract]   [Full Text] [Related]  

  • 36. Weight loss significantly reduces serum lipocalin-2 levels in overweight and obese women with polycystic ovary syndrome.
    Koiou E; Tziomalos K; Katsikis I; Kandaraki EA; Kalaitzakis E; Delkos D; Vosnakis C; Panidis D
    Gynecol Endocrinol; 2012 Jan; 28(1):20-4. PubMed ID: 21756081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lifestyle modifications alone or combined with hormonal contraceptives improve sexual dysfunction in women with polycystic ovary syndrome.
    Steinberg Weiss M; Roe AH; Allison KC; Dodson WC; Kris-Etherton PM; Kunselman AR; Stetter CM; Williams NI; Gnatuk CL; Estes SJ; Sarwer DB; Coutifaris C; Legro RS; Dokras A
    Fertil Steril; 2021 Feb; 115(2):474-482. PubMed ID: 33059886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity Exacerbates Irritable Bowel Syndrome-Related Sleep and Psychiatric Disorders in Women With Polycystic Ovary Syndrome.
    Tseng PH; Chiu HM; Tu CH; Wu MS; Ho HN; Chen MJ
    Front Endocrinol (Lausanne); 2021; 12():779456. PubMed ID: 34867827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
    Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
    Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progesterone Receptors and Proliferation of the Endometrium in Obese Women With Polycystic Ovary Syndrome-A Lifestyle Intervention Study.
    Paulson M; Sahlin L; Hirschberg AL
    J Clin Endocrinol Metab; 2017 Apr; 102(4):1244-1253. PubMed ID: 28388727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.